ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

An Impromptu Group Proposes Standards For Publication Of Genomics Research

October 1, 2010